Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment

医学 疾病 自然史 强直性脊柱炎 热情 末端炎 轴向骨架 重症监护医学 生活质量(医疗保健) 物理疗法 内科学 病理 银屑病性关节炎 解剖 护理部 肌腱
作者
Alexandros A. Drosos,Aliki I. Venetsanopoulou,Paraskevi V. Voulgari
出处
期刊:European Journal of Internal Medicine [Elsevier BV]
卷期号:117: 21-27 被引量:17
标识
DOI:10.1016/j.ejim.2023.06.026
摘要

Spondyloarthritis (SpA) is a chronic inflammatory disease that affects the axial skeleton (axSpA) and/or the peripheral joints (p-SpA) and entheses. The natural history of SpA in the decades of the 80 and 90 s involved a progressive disease with pain, spinal stiffness, ankylosis of the axial skeleton, structural damage of peripheral joints, and a poor prognosis. In the last 20 years, enormous advances in understanding and managing SpA have occurred. With the introduction of the ASAS classification criteria and MRI, early disease recognition is now possible. The ASAS criteria widened the spectrum of SpA to include all the disease phenotypes, such as radiographic (r-axSpA), non-radiographic (nr-axSpA), and p-SpA and extraskeletal manifestations. Nowadays, the treatment of SpA is based on a shared decision between patients and rheumatologists and includes non-pharmacological and pharmacological therapies. Moreover, the discovery of TNFα, IL-17, which play a pivotal role in disease pathophysiology, has revolutionized disease management. Thus, new targeted therapies and many biological agents are now available and used in SpA patients. TNFα inhibitors (TNFi), IL-17, and JAK inhibitors were proven to be efficacious, with an acceptable toxicity profile. Overall, their efficacy and safety are comparable with some differences. Sustained clinical disease remission, low disease activity, improvement of patient's quality of life, and prevention of progression of structural damage, are the results of the above interventions. The concept of SpA has changed in the last 20 years. The disease burden can be ameliorated by early and accurate diagnosis and targeting therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被果果123采纳,获得10
1秒前
共享精神的应助被LYriQue采纳,获得10
1秒前
99v587发布了新的文献求助10
1秒前
2秒前
HHOO完成签到,获得积分10
2秒前
4秒前
4秒前
4秒前
上官若男的应助被苦瓜采纳,获得10
6秒前
斯文败类的应助被江南达尔贝采纳,获得10
7秒前
9秒前
深情安青的应助被kong采纳,获得10
10秒前
lucky的应助被Xiiiii9采纳,获得10
10秒前
OCean完成签到,获得积分10
11秒前
科研通AI6.3的应助被zz采纳,获得30
13秒前
baozeNG完成签到,获得积分10
14秒前
科研通AI6.3的应助被dit采纳,获得10
14秒前
14秒前
刘刘发布了新的文献求助10
14秒前
star完成签到 ,获得积分10
15秒前
搜集达人的应助被qqqqqqqqqq采纳,获得10
16秒前
科研通AI6.2的应助被dudu采纳,获得10
17秒前
午盏完成签到 ,获得积分10
17秒前
17秒前
18秒前
20秒前
酷波er的应助被kong采纳,获得10
21秒前
22秒前
22秒前
星辰大海的应助被11采纳,获得10
22秒前
23秒前
年轻的寻桃完成签到,获得积分10
23秒前
AB完成签到 ,获得积分10
23秒前
经十路以东的应助被彩色青亦采纳,获得10
23秒前
23秒前
24秒前
无尘发布了新的文献求助10
24秒前
Liang完成签到,获得积分10
24秒前
zenghong发布了新的文献求助10
24秒前
Conqurd发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194332
求助须知:如何正确求助?哪些是违规求助? 9580146
关于积分的说明 21869842
捐赠科研通 7793919
什么是DOI,文献DOI怎么找? 3437579
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484371